Online Tai Chi Plus Fitbit After ACS (Mind2Move)

February 2, 2026 updated by: Gloria Y. Yeh, Beth Israel Deaconess Medical Center

Tai Chi Exercise and Wearable Feedback Technology to Promote Physical Activity in Acute Coronary Syndrome Survivors

This projects studies the role of tai chi exercise and wearable fitness trackers to promote physical activity in acute coronary syndrome (ACS) survivors.

Study Overview

Status

Active, not recruiting

Intervention / Treatment

Detailed Description

This is a two-site randomized controlled trial taking place at Beth Israel Deaconess Medical Center in Boston, MA and The Miriam Hospital in Providence, RI. Seventy (n=70) physically inactive ACS survivors will be randomized to either a 6-month group tai chi program (remotely-delivered classes on Zoom) integrated with a wearable self-monitoring/feedback device plus enhanced usual care (EUC), or to EUC alone. EUC will include usual care provided by participants' providers integrated with printed CHD risk factor education materials. Assessments will be conducted in-person at baseline, 6 months (end of treatment), and 9 months. Our primary outcomes will be focused on study feasibility and acceptability. Secondary outcomes include the following patient-centered outcomes: objectively measured (via accelerometry) moderate-vigorous physical activity, light physical activity, sedentary time, cognitive-behavioral constructs (exercise self-efficacy, intrinsic motivation, depression, stress, HRQL), and cardiometabolic measures (exercise capacity, body weight, lipid profile, blood pressure, fasting plasma glucose).

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Beth Israel Deaconess Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. History of ACS (unstable angina, NSTEMI, and STEMI, defined per current AHA/ACC criteria);
  2. Age ≥ 18;
  3. Being physically inactive (i.e., < 150 min/week of moderate-intensity aerobic PA);
  4. Absence of contraindications to physical exercise per the participant's provider evaluation;
  5. Access to a digital device with internet connection;
  6. Having an active email account and ability to check email at least weekly;
  7. Physician clearance to participate in low-moderate intensity exercise (tai chi), including a statement that there is no contraindication to exercise based on post-ACS stress test and other factors, as appropriate;
  8. English speaking

Exclusion Criteria:

  1. Inability or unwillingness to give informed consent;
  2. Blood pressure >200/110 or orthostatic systolic blood pressure decrease >20 mmHg at the baseline visit;
  3. Uncontrolled/untreated atrial or ventricular arrhythmias or 3rd degree AV block;
  4. Within 3 months of a diagnosis of pericarditis or myocarditis;
  5. Medical conditions likely to limit lifespan to less than one year;
  6. New York Heart Association (NYHA) functional class IV;
  7. Severe cognitive impairment (BOMC >10);139
  8. Orthopedic problems prohibiting TC practice;
  9. Ongoing TC or other mind-body training (i.e., meditation, TC, or yoga) at least weekly;
  10. Current enrollment in cardiac rehabilitation;
  11. Untreated severe depression (PHQ>=20);
  12. Conditions likely to affect study compliance (i.e., moving out of study area, substance use, ongoing untreated psychosis);
  13. Symptoms of unstable cardiovascular disease (e.g., shortness of breath or chest pain at rest and/or Canadian Cardiovascular Society Angina Class III-IV)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Tai chi + wearable
48 virtual tai chi classes on Zoom over 6 months plus assigned home practice of tai chi 3x a week plus daily use of a Fitbit fitness tracker will be required for this group.
The tai chi intervention will be delivered remotely via Zoom Enterprise. Participants will access classes on a phone, tablet, laptop, or desktop computer. Participants will attend 3 classes/week (each lasting 60 min) during weeks 1-12, 2 classes/week during weeks 13-16, and then 1 class every other week during weeks 17-24. Classes include tai chi warm-up exercises, breathing exercises, review and practice of tai chi forms, and cool-down exercises. Participants will be asked to practice tai chi at home 3x per week during the 6 month intervention period using an instructional video provided to them. The Fitbit fitness tracker will be given to each participant along with instructions on how to use the tracker and the Fitbit app on their personal device.
No Intervention: Enhanced usual care
Printed educational materials based on existing resources (e.g., AHA; Centers for Disease Control and Prevention) will be shared with subjects in this group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recruitment rate
Time Frame: Through study completion (an average of 3 years)
Recruitment rate will be evaluated with respect to rate of enrollment, defined as randomization into the trial.
Through study completion (an average of 3 years)
Retention rate
Time Frame: Through study completion (an average of 3 years)
Retention rate will be quantified by the proportion of subjects who remain in the study to complete our 9-month visit.
Through study completion (an average of 3 years)
Intervention enjoyment
Time Frame: 6 months
Intervention enjoyment will be assessed via qualitative interviews
6 months
Intervention adherence
Time Frame: Through study completion (an average of 3 years)
Intervention adherence will be measured by collection of class attendance and home practice data.
Through study completion (an average of 3 years)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Physical activity
Time Frame: Baseline, 6 and 9 months
Physical activity will be measured using accelerometers (Actigraph model wGT3X-BT, LLC, Fort Walton Beach, FL).
Baseline, 6 and 9 months
Systolic and diastolic blood pressure
Time Frame: Baseline, 6 and 9 months
Blood pressure will be measured using a Dinamap XL automated BP monitor according to current recommendations.
Baseline, 6 and 9 months
Body weight
Time Frame: Baseline, 6 and 9 months
Body weight will be measured using an electronic scale.
Baseline, 6 and 9 months
Height
Time Frame: Baseline
Height will be measured using a tape measure.
Baseline
Fasting glucose
Time Frame: Baseline, 6 and 9 months
Fasting glucose will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital.
Baseline, 6 and 9 months
Lipid panel
Time Frame: Baseline, 6 and 9 months
Lipid panel will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital.
Baseline, 6 and 9 months
hs-CRP
Time Frame: Baseline, 6 and 9 months
hs-CRP will be measured after a 12-hour fast according to standardized procedures. All blood samples will be sent to and analyzed at the Lifespan Laboratory located at the Rhode Island Hospital/The Miriam Hospital.
Baseline, 6 and 9 months
Quality of life assessed by SF-36
Time Frame: Baseline, 6 and 9 months
Quality of life will be measured using a short version (8 items) of the Health Survey Short Form (SF-36). Scores range from 0-100, with a higher score indicating a higher quality of life.
Baseline, 6 and 9 months
Intrinsic motivation
Time Frame: Baseline, 6 and 9 months
Intrinsic Motivation Inventory is a 22-item scale validated with four sub-scales: interest/enjoyment, perceived competence, perceived choice, and pressure/tension. A higher score is better, with a scoring range of 22-154.
Baseline, 6 and 9 months
Anxiety, Depression
Time Frame: Baseline, 6 and 9 months
Anxiety, Depression will be assessed using the Hospital Anxiety and Depression Scale, a self-administered questionnaire with two sub-scales (0-21) measuring anxiety and depression, with higher scores indicating greater psychological morbidity.
Baseline, 6 and 9 months
Stress
Time Frame: Baseline, 6 and 9 months
Stress will be measured using the Perceived Stress Scale (PSS) - a 10 items survey with scores ranging from 0 to 40, and higher scores indicating greater stress burden.
Baseline, 6 and 9 months
Mindful awareness
Time Frame: Baseline, 6 and 9 months
Mindful awareness will be assessed using the Five Facets of Mindfulness questionnaire (short form) a 15-item questionnaire that measures the five identified components of mindfulness meditation: observing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience. Scores ranges from 39-19, with a higher score being better.
Baseline, 6 and 9 months
Exercise self-efficacy
Time Frame: Baseline, 6 and 9 months
Exercise self-efficacy will be measured using the Self-Efficacy for Exercise Scale. This is a 9-item validated scale from McAuley's original barriers scale. Scores range form 9-28, with a higher score meaning more self-efficacy.
Baseline, 6 and 9 months
Exercise capacity
Time Frame: Baseline, 6 and 9 months
Exercise capacity will be assessed via the 6 min walk test (6MWT), a simple, safe and reliable first-line assessment of functional status that correlates with peak oxygen uptake.
Baseline, 6 and 9 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socio-demographics
Time Frame: Baseline
Age, sex, race/ethnicity, education, income, insurance status will be collected from the EMR using standard abstraction forms.
Baseline
Medical history
Time Frame: Baseline
Coronary risk factors; coronary revascularization procedures; ejection fraction; New York Heart Association class; CHD severity (one-, two- or three-vessel from coronary angiogram); co-morbidities; CR information (history of participation, reasons for decline); comorbidities (Charlson index); medications] will be abstracted from medical records using standard abstraction forms that have been validated in previous studies.
Baseline
Social support
Time Frame: Baseline
Social support will be measured with the Multidimensional Scale of Perceived Social Support is a 12-item, unidimensional tool to measure how one perceives their social support system, including the individual's sources of social support (i.e., family, friends, and significant others). Scores range from 12-84, with a higher score meaning more perceived social support.
Baseline
Neighborhood barriers to physical activity
Time Frame: Baseline
PANES (Physical Activity Neighborhood Environment Survey) also known as the International Physical Activity Prevalence Study Self-Administered Environmental Module is a 17-item Scale that can be used to assess the environmental factors for walking and bicycling in various neighborhoods. Scores range from 17-68, with higher scores indicating a neighborhood environment that is more conducive to physical activity.
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 27, 2024

Primary Completion (Estimated)

June 15, 2026

Study Completion (Estimated)

June 15, 2026

Study Registration Dates

First Submitted

January 6, 2023

First Submitted That Met QC Criteria

January 17, 2023

First Posted (Actual)

January 26, 2023

Study Record Updates

Last Update Posted (Actual)

February 4, 2026

Last Update Submitted That Met QC Criteria

February 2, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Coronary Syndrome

Clinical Trials on Tai chi + wearable

3
Subscribe